171 related articles for article (PubMed ID: 22820412)
1. New insights into meningioma: from genetics to trials.
Vranic A; Peyre M; Kalamarides M
Curr Opin Oncol; 2012 Nov; 24(6):660-5. PubMed ID: 22820412
[TBL] [Abstract][Full Text] [Related]
2. SMARCB1 mutations are not a common cause of multiple meningiomas.
Hadfield KD; Smith MJ; Trump D; Newman WG; Evans DG
J Med Genet; 2010 Aug; 47(8):567-8. PubMed ID: 20472658
[TBL] [Abstract][Full Text] [Related]
3. Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules.
Torres-Martín M; Kusak ME; Isla A; Burbano RR; Pinto GR; Melendez B; Castresana JS; Rey JA
Cancer Genet; 2015 Jun; 208(6):327-32. PubMed ID: 25981829
[TBL] [Abstract][Full Text] [Related]
4. Germline and somatic mutations in meningiomas.
Smith MJ
Cancer Genet; 2015 Apr; 208(4):107-14. PubMed ID: 25857641
[TBL] [Abstract][Full Text] [Related]
5. Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons.
Karsy M; Guan J; Cohen A; Colman H; Jensen RL
Neurosurg Clin N Am; 2016 Apr; 27(2):249-60. PubMed ID: 27012389
[TBL] [Abstract][Full Text] [Related]
6. Comment on the article "Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri" by van den Munckhof et al.
Prescott TE; Smith MJ; Evans DG
Neurogenetics; 2012 Feb; 13(1):103-4. PubMed ID: 22203059
[No Abstract] [Full Text] [Related]
7. Medical management of meningioma in the era of precision medicine.
Gupta S; Bi WL; Dunn IF
Neurosurg Focus; 2018 Apr; 44(4):E3. PubMed ID: 29606052
[TBL] [Abstract][Full Text] [Related]
8. Pediatric rhabdoid meningioma: a morphological, immunohistochemical, ultrastructural and molecular case study.
Buccoliero AM; Castiglione F; Rossi Degl'Innocenti D; Franchi A; Sanzo M; Cetica V; Giunti L; Sardi I; Mussa F; Giordano F; Genitori L; Taddei GL
Neuropathology; 2011 Feb; 31(1):59-65. PubMed ID: 20408963
[TBL] [Abstract][Full Text] [Related]
9. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I
Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177
[TBL] [Abstract][Full Text] [Related]
10. Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas.
Christiaans I; Kenter SB; Brink HC; van Os TA; Baas F; van den Munckhof P; Kidd AM; Hulsebos TJ
J Med Genet; 2011 Feb; 48(2):93-7. PubMed ID: 20930055
[TBL] [Abstract][Full Text] [Related]
11. Current treatment options for meningioma.
Apra C; Peyre M; Kalamarides M
Expert Rev Neurother; 2018 Mar; 18(3):241-249. PubMed ID: 29338455
[TBL] [Abstract][Full Text] [Related]
12. Animal models of meningiomas.
Mawrin C
Chin Clin Oncol; 2017 Jul; 6(Suppl 1):S6. PubMed ID: 28595424
[TBL] [Abstract][Full Text] [Related]
13. Current standing and frontiers of gene therapy for meningiomas.
De La Garza-Ramos R; Flores-Rodríguez JV; Martínez-Gutiérrez JC; Ruiz-Valls A; Caro-Osorio E
Neurosurg Focus; 2013 Dec; 35(6):E4. PubMed ID: 24289129
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of meningiomas: Building the roadmap towards personalized therapy.
Peyre M; Kalamarides M
Neurochirurgie; 2018 Mar; 64(1):22-28. PubMed ID: 25245924
[TBL] [Abstract][Full Text] [Related]
15. Giant frontal colliding meningiomas in a child: histopathologic, cytogenetic, and ultrastructural descriptions of a unique case.
El Jamal SM; Raja A; Saad AG
Pediatr Dev Pathol; 2011; 14(4):333-8. PubMed ID: 21417911
[TBL] [Abstract][Full Text] [Related]
16. Meningiomas and neurofibromatosis for the oncologist.
Schrell UM; Fahlbusch R; Adams EF
Curr Opin Oncol; 1994 May; 6(3):247-53. PubMed ID: 8080853
[TBL] [Abstract][Full Text] [Related]
17. The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma.
Chamberlain MC
Curr Opin Oncol; 2012 Nov; 24(6):666-71. PubMed ID: 22759739
[TBL] [Abstract][Full Text] [Related]
18. Meningioma: an update.
Lusis E; Gutmann DH
Curr Opin Neurol; 2004 Dec; 17(6):687-92. PubMed ID: 15542977
[TBL] [Abstract][Full Text] [Related]
19. Future treatment modalities for meningiomas: targeting of neurofibromatosis type 2 and Ras-regulated pathways.
Evans JJ; Lee JH; Park YS; Jeun SS; Harwalkar JA; Safayhi H; Golubic M
Neurosurg Clin N Am; 2000 Oct; 11(4):717-33. PubMed ID: 11082181
[No Abstract] [Full Text] [Related]
20. [Meningiomas: new prognostic factors].
Sanz Esponera J
An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
